Trichotillomania in Long COVID Successfully Treated with Escitalopram: A Case Report

    Ryuji Hata, Hiroko Sugawara, Reiko Hayashi, Yuta Okamoto, Reiko Nishihara, Takahiro Yamasaki, Akito Hatanaka, Kohei Harada, Hikaru Hori
    Image of study
    TLDR Escitalopram helped a woman with hair-pulling due to long COVID.
    This case report describes a 53-year-old woman who developed trichotillomania (TTM) as a symptom of long COVID, characterized by compulsive hair-pulling leading to hair loss. The patient, who had no prior psychiatric history, began exhibiting symptoms such as irritability, restlessness, and hair-pulling one week after contracting COVID-19. Upon admission to the hospital, she was treated with escitalopram, a selective serotonin reuptake inhibitor (SSRI), which led to significant improvement in her symptoms. Her hair gradually regrew, and she was discharged after approximately 3 months. This case suggests that TTM in long COVID may be effectively treated with escitalopram, although further research is needed to understand the pathophysiology and treatment of TTM and long COVID.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 6 results

      community Reverse Tressless...LOL O_O O_O

      in Satire  131 upvotes 2 weeks ago
      A person with a full head of hair chose to laser it off, sparking disbelief and discussions about hair loss treatments like Minoxidil and Finasteride. Many users questioned the decision, suggesting it might be a troll post or an extreme reaction to balding concerns.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Similar Research

    5 / 1000+ results